These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32885810)

  • 1. Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression.
    Fugger G; Dold M; Bartova L; Mitschek MMM; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Fabbri C; Frey R; Kasper S
    Int J Neuropsychopharmacol; 2020 Dec; 23(9):571-577. PubMed ID: 32885810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.
    Dold M; Bartova L; Mendlewicz J; Souery D; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Acta Psychiatr Scand; 2018 May; 137(5):401-412. PubMed ID: 29492960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):752-760. PubMed ID: 29705022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.
    Dold M; Bartova L; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
    J Affect Disord; 2018 Feb; 227():254-259. PubMed ID: 29107818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.
    Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):625-632. PubMed ID: 28579072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study.
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):777-785. PubMed ID: 31006562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression.
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109638. PubMed ID: 31054944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder.
    Fugger G; Bartova L; Dold M; Fabbri C; Fanelli G; Zanardi R; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 114():110480. PubMed ID: 34826558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine and treatment-resistant depression.
    Chen SP
    Prog Brain Res; 2023; 281():149-173. PubMed ID: 37806714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.
    Dold M; Bartova L; Kautzky A; Serretti A; Porcelli S; Souery D; Mendlewicz J; Montgomery S; Zohar J; Kasper S
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1305-1313. PubMed ID: 30446357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression.
    Bartova L; Dold M; Fugger G; Kautzky A; Mitschek MMM; Weidenauer A; Hienert MG; Frey R; Mandelli L; Zohar J; Mendlewicz J; Souery D; Montgomery S; Fabbri C; Serretti A; Kasper S
    Depress Anxiety; 2021 Sep; 38(9):896-906. PubMed ID: 34110066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression.
    Bartova L; Fugger G; Dold M; Swoboda MMM; Zohar J; Mendlewicz J; Souery D; Montgomery S; Fabbri C; Serretti A; Kasper S
    J Psychiatr Res; 2021 Sep; 141():167-175. PubMed ID: 34216945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S
    Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.
    Dold M; Bartova L; Kautzky A; Porcelli S; Montgomery S; Zohar J; Mendlewicz J; Souery D; Serretti A; Kasper S
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine symptomatology and major depressive disorder.
    Ligthart L; Penninx BW; Nyholt DR; Distel MA; de Geus EJ; Willemsen G; Smit JH; Boomsma DI
    Cephalalgia; 2010 Sep; 30(9):1073-81. PubMed ID: 20713558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity of Migraine, Major Depressive Disorder, and Generalized Anxiety Disorder in Adolescents and Young Adults.
    Dindo LN; Recober A; Haddad R; Calarge CA
    Int J Behav Med; 2017 Aug; 24(4):528-534. PubMed ID: 28032323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders.
    Ligthart L; Hottenga JJ; Lewis CM; Farmer AE; Craig IW; Breen G; Willemsen G; Vink JM; Middeldorp CM; Byrne EM; Heath AC; Madden PA; Pergadia ML; Montgomery GW; Martin NG; Penninx BW; McGuffin P; Boomsma DI; Nyholt DR
    Hum Genet; 2014 Feb; 133(2):173-86. PubMed ID: 24081561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.
    Dold M; Bartova L; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    J Psychiatr Res; 2017 Aug; 91():1-13. PubMed ID: 28284107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression comorbidity in migraine.
    Amoozegar F
    Int Rev Psychiatry; 2017 Oct; 29(5):504-515. PubMed ID: 28681617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between eating disorders and migraine may be explained by major depression.
    Mustelin L; Raevuori A; Kaprio J; Keski-Rahkonen A
    Int J Eat Disord; 2014 Dec; 47(8):884-7. PubMed ID: 24888633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.